Typically miRNAs interact with specific mRNAs through complementary base-pairing to influence the translation or stability of the target mRNA molecule. A rat study suggests that maternal stress ...

Further proof of great versatility of Altamira’s platform for extrahepatic RNA delivery Circular mRNA significantly increasing protein expression vs. linear mRNA Filed provisional patent application, ...

Kaneka has successfully defended its patent for stabilizing Ubiquinol. On December 20, 2024, Kaneka Corporation won its lawsuit against Designs for Health, Inc. and American River Nutrition, LLC for ...

Russia’s mRNA vaccine targets cancer using AI-powered personalisation Free distribution for Russian citizens begins in 2025 The vaccine trains the immune system to fight cancer effectively ...

一年一度的ICCAD不仅是集成电路设计公司的聚会，更是国产EDA公司集体展示自身技术实力和研发成果的舞台。作为IC产业链条中相对较薄弱的一环 ...

The technology-driven Nasdaq-100 has delivered an impressive performance in 2024, posting a nearly 30% return year-to-date. This strong showing has been propelled by a few standout stocks, while ...

As technology continues to evolve, consumer electronics have become essential to everyday life. SHENZHEN, China, Dec. 21, 2024 /PRNewswire/ -- As technology continues to evolve, consumer electronics ...

Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks EDA Group Holdings Limited announced a change in its compliance adviser due to the resignation of the officer ...

Silvaco specializes in TCAD, EDA software, and SIP solutions for semiconductor design and digital twin modeling, serving various markets including automotive and 5G/6G technologies. The company is ...

In a major medical breakthrough, Russia has unveiled the development of an mRNA-based vaccine aimed at treating cancer. According to reports by the state-run media outlets, the vaccine will be ...

Russia announces the development of an mRNA cancer vaccine, slated for a 2025 launch. Pre-clinical trials demonstrate tumor suppression and metastasis reduction. AI integration promises to ...

Russia announced that it had developed an mRNA vaccine for cancer patients. The vaccine will be available from early 2025 and will be distributed for free. The vaccine will cost the Russian government ...